Atlas Trials

Study of the Safety, Tolerability, and Pharmacokinetics of LV232 Capsules in Chinese Healthy Volunteers

Clinical trial NCT06070857 · COMPLETED

Trial details

NCT number
NCT06070857
Sponsor
Vigonvita Life Sciences
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy Subjects
Start date
2023-10-05
Primary completion
2025-11-17
Enrollment
81

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.